Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis

Objective The aim of the current study was to determine the incidence of organ function preservation failure (OFPF) in patients with head and neck squamous cell carcinoma (HNSCC) treated by (chemo)radiotherapy and to identify its risk factors. Study Design Retrospective cohort analysis. Setting Tertiary cancer care center. Subjects and Methods A single-center retrospective cohort analysis was done (n = 703) in which OFPF after (chemo)radiotherapy was assessed. OFPF was defined as local failure or pure functional failure in the absence of local failure because of major surgical intervention (total laryngectomy, commando resection, permanent tracheostomy) or feeding tube dependence >2 years. Results OFPF occurred in 153 patients (21.8%). Reasons for OFPF were local failure in 103 patients (14.6%) and functional failure in 50 patients (7.2%). Evidence of functional failure included need for total laryngectomy (n = 9, 1.3%), commando resection (n = 2, 0.3%), permanent tracheostomy (n = 16, 2.3%), and/or long-term feeding tube for functional reasons (n = 23, 3.3%). In a Cox proportional hazards model, OFPF was worse for patients with T4 tumors (hazard ratio [HR] <0.5 and P < .001 for all other stages), for laryngeal vs oropharyngeal cancer (HR, 1.83; 95% confidence interval [CI], 1.20-2.79, P = .005, hypopharyngeal not significant), and for smokers (HR, 1.68; 95% CI, 1.10-2.56, P = .015). Exploratory multivariate analysis by tumor site showed that T4 tumor and pretreatment tracheostomy were the strongest predictive factors for OFPF in laryngeal and hypopharyngeal carcinoma while T4 tumor and smoking were predictive for poor OFPF in oropharyngeal carcinoma. Conclusion This work shows a detrimental effect of smoking on functional outcomes after (chemo-)radiotherapy for HNSCC. Moreover, T4 tumor, laryngeal subsite, and pretreatment tracheostomy are strong predictors of OFPF.

[1]  D. Deschler,et al.  Oncologic and functional outcomes of pretreatment tracheotomy in advanced laryngeal squamous cell carcinoma: A multi-institutional analysis. , 2018, Oral oncology.

[2]  J. Pignon,et al.  Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  K. Fung,et al.  Evaluating organ preservation outcome as treatment endpoint for T1aN0 glottic cancer , 2017, The Laryngoscope.

[4]  C. C. Estomba,et al.  Persistent Tracheostomy after Organ Preservation Protocol in Patients Treated for Larynx and Hypopharynx Cancer , 2017 .

[5]  A. Garden,et al.  Long‐term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches , 2016, Head & neck.

[6]  R. Jiang,et al.  Transoral robotic surgery for early glottic carcinoma involving anterior commissure: Preliminary reports , 2016, Head & neck.

[7]  Yue Zhao,et al.  Risk factors for late dysphagia after (chemo)radiotherapy for head and neck cancer: A systematic methodological review , 2016, Head & neck.

[8]  M. Spiotto,et al.  Predictors and outcomes for chronic tracheostomy after chemoradiation for advanced laryngohypopharyngeal cancer , 2016, The Laryngoscope.

[9]  G. Poissonnet,et al.  Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program , 2016, European Archives of Oto-Rhino-Laryngology.

[10]  S. Roman,et al.  Complications and mortality following surgery for oral cavity cancer: Analysis of 408 cases , 2015, The Laryngoscope.

[11]  N. Aaronson,et al.  Prevalence of swallowing and speech problems in daily life after chemoradiation for head and neck cancer based on cut-off scores of the patient-reported outcome measures SWAL-QOL and SHI , 2015, European Archives of Oto-Rhino-Laryngology.

[12]  E. Babin,et al.  Laryngeal preservation in ENT oncology. Retrospective series of 246 patients managed in the Caen University Hospital and François Baclesse Cancer Care Center between 1998 and 2008. , 2015, European annals of otorhinolaryngology, head and neck diseases.

[13]  Abie H. Mendelsohn,et al.  CO2 laser cordectomy for glottic squamous cell carcinoma involving the anterior commissure: voice and oncologic outcomes , 2015, European Archives of Oto-Rhino-Laryngology.

[14]  G. Poissonnet,et al.  Long-term functional outcomes and quality of life after oncologic surgery and microvascular reconstruction in patients with oral or oropharyngeal cancer , 2014, Acta oto-laryngologica.

[15]  H. Comber,et al.  Smoking at Diagnosis Is an Independent Prognostic Factor for Cancer-Specific Survival in Head and Neck Cancer: Findings from a Large, Population-Based Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[16]  R. Riera,et al.  Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  S. Pradhan,et al.  Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans‐oral CO2 laser microsurgery , 2013, The Laryngoscope.

[18]  R. Weber,et al.  Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  G. Gunn,et al.  Late dysphagia after radiotherapy‐based treatment of head and neck cancer , 2012, Cancer.

[20]  S. Kannan,et al.  Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  D. Rietveld,et al.  Five‐year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra‐arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer , 2012, Head & neck.

[22]  F. Hilgers,et al.  Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy. , 2012, Archives of otolaryngology--head & neck surgery.

[23]  M. Kupferman,et al.  Outcomes of Elective Total Laryngectomy for Laryngopharyngeal Dysfunction in Disease-Free Head and Neck Cancer Survivors , 2012, Otolaryngology Head & Neck Surgery.

[24]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[25]  J. Pignon,et al.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[27]  A. Hart,et al.  The impact of treatment time and smoking on local control and complications in T1 glottic cancer. , 1998, International journal of radiation oncology, biology, physics.

[28]  A. Hart,et al.  Staging and prognostic factors in carcinoma of the base of the tongue. , 1992, Clinical otolaryngology and allied sciences.